Rohit Bhuta

Group CEO, Oz Medicann Group

Oz Medicann Group is an Australian health and biotechnology company focused on clinically supported, evidence-led medical solutions.

Professor Alan Bensoussan

PhD, MSc(Res), PGDipEd, BSc, DipAc, MAICD Emeritus Professor of Integrative Medicine and former Foundation Director of the NICM Health Research Institute at Western Sydney University. Professor Bensoussan has contributed extensively to national policy, including serving as Chair of the TGA Advisory Committee for Complementary Medicines and advising the World Health Organisation.